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Summary 
Constitutive major histocompatibility complex (MHC) class II gene expression is tightly restricted 
to antigen presenting cells and is under developmental control Ceils of the B cell lineage acquire 
the capacity to express MHC class II genes early during ontogeny and lose this property during 
terminal differentiation into plasma cells. Cell fusion experiments have suggested that the extinction 
of MHC class II expression in plasma cells is due to a dominant repression, but the underlying 
mechanisms are not understood. CIITA was recently identified as an MHC class II transactivator 
that is essential for MHC class II expression in B lymphocytes. We show here that inactivation 
of MHC class II genes in plasmocytes is associated with silencing of the CIITA gene. Moreover, 
experimentally induced expression of CIITA in plasmocytes leads to reexpression of MHC class 
II molecules to the same level as that observed on B lymphocytes. We therefore conclude that 
the loss of MHC class  II expression observed upon terminal differentiation of B lymphocytes 
into plasmocytes results from silencing of the transactivator gene CIITA. 
M 
HC class II molecules play a fundamental role as re- 
striction molecules for antigen presentation to the TCK 
of CD4 + cells (1,  2).  Surface expression of MHC  class  II 
products is restricted to APCs including B lymphocytes, mac- 
rophages, dendritic cells, thymic epithelium, and activated 
T cells (3-5). MHC class II expression is regulated throughout 
B cell development. Class II genes are silent in murine pro-B 
cells (6-9) and subsequently turned on in pre-B cells (8, 9). 
In humans, the expression of MHC class II molecules coin- 
cides with some of the earliest determinants of B calls devel- 
opment, such as CD10 and CD34 (10, 11). The capacity to 
express class II molecules is maintained throughout the life 
of B  lymphocytes until their terminal differentiation into 
plasma cells, when class  II genes are shut off (12). 
MHC class II expression on B lymphocytes is functionally 
relevant for an efficient humoral response against T cell-de- 
pendent antigens (13).  Antigens in their native conforma- 
tion are captured by surface Ig molecules, internalized, pro- 
cessed, and presented to T cells in a MHC-restricted fashion 
(1, 2). Although constitutive expression of class II genes is 
restricted to professional APCs, many cell types can be in- 
duced to express these molecules by external stimuli, in par- 
ticular by IFN-3: and IL-4 (4,  14-18).  Constitutive as well 
as inducible expression of MHC class II genes is controlled 
via c/s-acting DNA sequences that are present in all MHC 
class II promoters (19,  20).  These c/s-acting sequences are 
known as the class II consensus boxes: W, X1, X2, and Y. 
Several proteins that bind to these sequences have been iden- 
tiffed  and  some  of  them  cloned.  In  addition,  a  non- 
DNA-b'mding MHC class II transactivator (CIITA) 1 protein 
has been cloned by genetic complementation ofa MHC class 
II regulatory mutant (21).  CIITA is the first gene shown to 
be affected and mutated in primary MHC class II deficiency, 
and expression of CIITA is absolutely reqttired for MI-IC class 
II gene expression in B lymphocytes (21).  The tissue distri- 
bution of CIITA mKNA correlates tightly with that of MHC 
class II genes. CIITA gene activation is also involved in MHC 
class  II induction by IFN-'y and TNF-ot (21a,  and Silacci, 
P., A. Mottet, V. Steimle, and B. Mach, manuscript in prep- 
aration). 
Although both constitutive and inducible expression of 
MHC class  II genes have been studied intensively, little is 
known about the extinction of MHC class II gene expres- 
sion during differentiation of mature B cells into plasma cells. 
Previous work (22, 23) involving cell fusion experiments sug- 
gested that the lack of MHC class II gene expression in plas- 
mocytes is due to a dominant repression mechanism. It is 
also known that class II promoters are unoccupied in vivo 
class  II-negative murine plasmacytoma calls  (24). 
1 Abbret,  iations used in th/s paper:. CAT, chlomamphenicol  acetyl transferase; 
CIITA, class II transactivator; TBP,  TATA-binding protein; X2BP,  X2 
binding protein. 
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tinction is operating directly at the level of MHC class II 
gene transcription or rather at the level of the regulation of 
a positive trans-acting factor involved in class II gene regula- 
tion. Results presented here show that repression of MHC 
class II expression in plasma cells correlates with the loss of 
expression of the MHC class II transactivator CIITA. More 
importantly, experimentally induced expression of CIITA in 
both human and mouse plasmocytes restores MHC class II 
transcription to levels comparable to that observed in mature 
B cells. We conclude therefore, that the extinction of MHC 
class II expression observed in the terminal differentiation of 
B lymphocytes into plasmocytes results from silencing of the 
MHC class II transactivator gene CIITA. 
Materiah and Methods 
Plasmids Construction and Oligonucleotides.  The chloramphenicol 
acetyl transferase (CAT) expression vectors used in this study were 
derived from pOCAT (25) and pBLCAT3 (26). A HadlI-SacI frag- 
ment containing the -150 to +6 bp of the DRA promoter was 
inserted upstream of the CAT gene into pOCAT, to obtain the 
pDKACAT plasmid. The SV40 early promoter was obtained by 
a SalI-BamHI digestion of pSG5 (Stratagene, La Jolla, CA) and 
inserted in pBLCAT3. 
The riboprobes used to detect HLA-DRA, CIITA, and TATA- 
binding proteins (TBP) mR.NA have all been described previously 
(21, 27). The plasmids used for the transfection  were EBO-Sfa/CIITA 
(21) and EBO-76PL, which was generated from EBO-Sfi (21) by 
deleting the Sfi-CAT-Sfi cassette. 
The WXY oligonucleotide is the HindlII-BglII  fragment de- 
rived from pDRsyn (28). The WX2 oligonucleotide has been de- 
scribed previously (29). 
Celt Culture and Transfections.  The B lymphoma cell lines RAJI 
and RJ2.2.5  were grown in KPMI-1640 medium  supplemented 
with 2 mM t-glutamine,  10% FCS, 10 U/ml penicillin, and 10 
#g/ml streptomycin. The SKO human myeloma cell line (ATCC 
8033; American Type Culture Collection,  Rockville, MD) was 
grown in the same medium supplemented  with 15% FCS and I mM 
Na-pyruvate. 
5  x  106 cells were used for each transfection. The cells were 
washed once in RPMI-1640 and then resuspended in 0.7 ml of 
RPMI-1640. DNA was added and the samples were incubated on 
ice for 10 min. The cells were then electroporated with a 250 
W960/zF pulse (Gene Pulser; Bio-Rad Laboratories, Richmond, 
CA). The electroporated cells were then resuspended in 10 ml of 
complete medium  and after 48 h they were harvested for enzy- 
matic activity analysis. 
The total amount of plasmid DNA used in each transfection 
was maintained constant, 400/~g Escherichia coli tRNA was added 
as carrier, and 3/zg pSV2AP was added as an internal control. Stable 
transfectants were obtained by drug selection. Hygromycin (Cal- 
biochem, San Diego, CA) was added at 100/~g/m148 h after trans- 
fections. The selections were complete after 2 wk. 
Flow Cytofluorometric  Analysis.  Surface  expression  of HLA mol- 
ecules on RAJI and SKO cell lines was analyzed by flow cyto- 
fluorometry using a FACScan  |  flow cytometer (Becton Dickinson 
& Co., Mountain View, CA). The antibodies used were 2.06 (30) 
specific  for HLA-DR, Ti22 (31) for HLA-DOo B7/21 (32) for DP, 
and w6/32 for MHC class I. Cells were incubated with the anti- 
bodies in a reaction mixture containing lx  PBS, 10% nonstimu- 
lated rabbit serum (NRS),  and 1% BSA for 30 min on ice. The 
cells were then washed and incubated with FITC-hbeled anti-mouse 
IgG (Serotec  Ltd., Oxford, UK) for 15 min on ice and subsequently 
washed twice before the FACS  |  analysis. 
CAT Assays.  Half of the harvested cells were used for placental 
alkaline phosphatase (PAP) assay (33) and the rest were used for 
CAT assay essentially  as previously  described (34). The results were 
quantified by excision of the acetylated and nonacetylated 14C- 
chloramphenicol forms from the chromatograms and direct scin- 
tilhtion counting.  The results obtained were corrected for trans- 
fection ef~ciency  on the basis of the PAP assay. The actual percent 
acetyhtion obtained with the SV40 early promoter was 83.2% (Raji 
cells) and 79.0% (SKO cells) for 30/zg of protein. All results with 
the DRA promoter are expressed as percent activity obtained with 
the SV40 promoter. 
In Vivo Footprint Analysis, Nuclear Extract Preparation, and Gel 
Retardation Assays.  In vivo footprint analyses were performed as 
previously described (35), using Vent DNA Polymerase (New En- 
gland Biolabs, Beverly,  MA) for all the steps of the ligation-mediated 
PCR reaction (LMPCR).  The sequences of the oligonucleotides 
used and the incubation temperatures for LMPCR reactions were 
the same as those used by Kara and Glimcher (36). 
Nuclear extracts from RAJI and SKO cell lines were prepared 
from 1.5-2  x  10  s cells as described previously (37). 
For electrophoretic mobility shift assays, binding was performed 
in a final volume of 20/zl containing 12% glycerol, 12 mM Hepes, 
pH 7.9, 60 mM KC1, 5 mM MgClz, 0.12 mM EDTA, 0.3 mM 
PMSF, 0.3  mM  dithiothreitol,  1 /~g poly(dI-dC).poly(dI-dC), 
",~20,000 cpm 3zp-labeled  probe, and 8/~g nuclear protein. Com- 
petitors were added at the same time as the labeled probe. Reaction 
mixtures were incubated for 30 rain on ice or at 20~  and the 
DNA-protein complexes were resolved on a 4% polyacrylamide 
0.25x  Tris-borate/EDTA (TBE) gels (lx  TBE  =  89 mM "Iris, 
89 mM boric add, and 2 mM EDTA). 
RNase Protection  Assay.  Total KNA was extracted from frozen 
cell pellets by using guanidium isothiocyanate (38). The plasmids 
containing CIITA and TBP cDNA fragments were linearized and 
transcribed with T3 RNA polymerase and SP6 polymerase, respec- 
tively (Boehringer Mannheim, Mannheim, Germany) in order to 
synthesize the 3zp-hbeled  riboprobes complementary to CIITA and 
TBP mRNAs. Reactions were performed at conditions described 
(18). Hybridization  of 2  x  10  s cpm of the riboprobe with 5 or 
10/zg total RNA was done in 80% formamide, 40 mM Pipes, pH 
6.4, 0.4 M NaC1, and 1 mM EDTA at 50~  overnight. The samples 
were then digested in a volume of 300/zl, with 10/~g RNase A 
and 1 U RNase T1 at 25~  for 30 min. After subsequent treat- 
ment with 50/~g proteinase  K in the presence  of 1% SDS for 15 min 
at 37~  the protected RNA fragments were extracted twice with 
phenol-chloroform,  ethanol precipitated, and resolved  on denaturing 
6% polyacrylamide-8 M urea gels. 
Results 
MHC Class II Promoters Are Silent in Plasmocytoma  Cells. 
Flow cytofluorometric analysis,  Northern blots, and RNase 
protection experiments have demonstrated a lack of expres- 
sion of HLA class II molecules (HLA-DR, -DQ, and -DP) 
and mRNA in the plasmocytoma call line SKO (data not 
shown). To determine whether this lack of expression is con- 
trolled at the level of transcription, transient transfection assays 
were performed using a CAT expression vector in which ex- 
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150 bp of the HLA-DKA promoter. As positive control, an 
SV40 early promoter-CAT construct was used. Transfections 
were performed in parallel in a B cell line (RAJI)  and in a 
plasmocytoma cell line  (SKO).  DRA-driven  CAT activity 
is high in the class II-positive RAJI cell line (23%  of that 
obtained using the SV40 early promoter) (Fig.  1, columns 
I  and 2) whereas it is undetectable in the class  II-negative 
SKO plasmocyte cell line (1.5%  of the SV40 control) (Fig. 
1, columns 3  and 4).  The DKA promoter is  thus inactive 
in plasmocytes, indicating that  the mechanism responsible 
for extinction of MHC  class  II genes operates at  the tran- 
scriptional level.  Moreover, these data demonstrate that ex- 
tinction of MHC class  II genes is mediated by the  150-bp 
promoter proximal region. This segment of DNA contains 
all the c/s-acting elements previously defined to be important 
for tissue specificity and inducibility of MHC class  II gene 
transcription. 
In general, the state of occupancy of MHC class II promoters 
in vivo correlates well with the activity of these promoters 
(24, 36). In vivo DMS (dimethylsulfate) footprinting experi- 
ments were performed and occupation of the W,  X1,  X2, 
and Y c/s-acting elements were analyzed. In MHC class II-posi- 
tire RAJI cells, a general occupation of the DRA promoter 
region is observed (36, and Fig. 2, lane I  and 2). Particularly 
evident is the protection at the guanosine residues  -  104 (XI 
box),  -  93 (X2 box),  -  68,  -  67 (Y box)  - 48 (octamer [O] 
sequence), and  -53.  Weaker protection is also observed for 
positions -  118 and -  122 (W box),  -  98 (X1 box), and  -  71 
(Y box).  In the plasmocytoma cell line SKO,  on the other 
hand,  none of the above positions is protected,  indicating 
that the promoter is bare (Fig. 2, lanes 3  and 4). This is in 
agreement with the situation observed in mouse plasmocy- 
toma cells (24).  We therefore conclude that MHC  class  II 
promoters are not occupied and are inactive in plasmocytes. 
Normal Pattern of  Protein Binding to MHC Class II  Promoters 
in Plasmocytes.  Because of the inactivity and lack of occupancy 
of MHC class  II promoters in plasmocytes, we studied the 
Figure  2.  In vivo footprint analysis reveals a bare HLA-DRA promoter 
in plasmocytoma cells. RAJI (columns 1 and 2) and SKO (columns 3 and 
4) cells were incubated with DMS. After purification, the DNA was deax~ 
by piperidine treatment, at positions corresponding to modified guano- 
sine. Cleaved fragments spanning the DRA promoter region were amplified 
by LMPCR and resolved on a 6% polayacrylamide-8 M urea gel. Purified 
DNAs from RAJI (column I) and SKO (column./) were also treated with 
DMS, cleaved with piperidine, and then amplified by LMPCR, in order 
to have the complete guanosine pattern corresponding to the upper strand 
of DRA promoter region. Positions of the W, X1, X2, and Y dements 
and the protected positions observed in RAJI are indicated. 
Figure  1.  MHC class II expression extinction involves a transcriptional 
mechanism acting via the proximal promoter of these genes. ILAJI (columns 
I  and 2) and SKO (columns 3  and 4) cell lines were transfected  with 
pSVpCAT (columns 2 and 4), and pDRA150 (columns I and 3) plasmids, 
by electroporation. 48 h  after transfection, the CAT activity present in 
the transected cells was determined. The CAT activity obtained with the 
DILA promoter is expressed as a percentage of the activity obtained with 
the SV40 early promoter. 
presence or absence of known class II promoter-binding pro- 
teins by electrophoretic mobility shift assays. Nuclear extracts 
from the B cell line Raji were used as a positive control. Three 
major specific bands are obtained with WXY oligo, which 
spans all the relevant promoter dements (Fig. 3, hne I). Com- 
petition experiments using unlabeled oligonucleotides allowed 
us to determine that these three bands are due to NF-Y, RF-X, 
and to the known cooperative binding between NF-Y and 
RF-X (39) (data not shown). The binding pattern observed 
is identical between nuclear extracts derived from the plas- 
mocytoma cell line SKO  (Fig. 3, lane 4) and the RAJI cell 
line, indicating that RF-X and NF-Y  are present normally 
in the class  II-negative plasmocytes. 
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of the DRA promoter is not affected in nuclear extracts from plasmocy- 
toma ceils. Nuclear extract prepared from RAJI (lanes 1, 3, and 5) and 
SKO (lanes 2, 4, and 6) cells were used in gel retardation assays with the 
WXY oligonudeotide containing all the class II consensus boxes (lanes 
I and 2), and with an oligonuclentide WX2, spanning the W, X1, and 
X2 boxes. With the WX2 oligonudeotide, incubation  temperatures used 
were 0~  (lanes 3 and 4) and 20~  (lanes 5 and 6). 
To analyze X2 binding proteins (X2BP), we used condi- 
tions that have allowed us to demonstrate cooperativity in 
binding between RF-X and X2BP (40, 40a). With an oligo- 
nudeotide that spans the W, X1, and X2 boxes, a major specific 
band formed by ILF-X is observed when the binding reac- 
tion is performed at 0~  whereas at 20~  an additional band 
consisting of RF-X bound together with X2BP is formed 
(Fig. 3, lanes 3 and 5).  Again the RAJI and SKO extracts 
give identical binding patterns (Fig.  3, compare lanes 3, 4 
and lanes 5, 6), indicating that X2BP is also normally present. 
These results thus demonstrate that, although MHC class 
II promoters are inactive and are not occupied in plasmo- 
cytes, the different nuclear transcription factors which can 
bind to MHC class II promoters in vitro are all present in 
these class II-negative cells. Therefore no impairment in the 
DNA binding ability can be invoked to account for the inac- 
tivity of MHC class II promoters. 
Plasmocytes Do Not Express the MHC Class II Transactivator 
CIITA.  In ~_dd_ition  to DNA-binding proteins such as RF-X, 
NF-Y, and X2BP, which are expressed in a ubiquitous fashion, 
expression of class II genes requires the MHC class II trans- 
activator  CIITA (21). Expression of CIITA is known to be 
tightly regulated (21, 21a, and Steimle,  V., A. Mottet and 
B. Mach, unpublished observations).  To explore the possi- 
bility of a role of CIITA in the negative control of MHC 
class II expression in plasmocytes,  we first analyzed  its ex- 
pression in these cells. The expression of CIITA gene was 
assayed by RNase protection experiments using a probe that 
protects 225 nucleotides of CIITA mRNA in MHC class 
II-positive B cells (Fig. 4, lane I). With RNA derived from 
plasmocytoma cells however, no protected fragment is ob- 
served (Fig.  4, lane 2), even after prolonged exposure.  We 
therefore conclude that the MHC class II transactivator CIITA 
is not expressed in plasmocytes and that this might be respon- 
sible for the lack of expression of MHC class II genes in these 
ceils. 
Experimentally Induced  Expression of  CIITA Can Restore  MHC 
Class II Gene Expression in Plasmocytes.  To test this hypoth- 
esis, we transfected  EBO-76PL (control vector) and EBO- 
Sfi/CIITA (full-length CIITA eDNA in an expression vector) 
(21) into the class II-negative plasmocyte cell line SKO and 
analyzed the effect of CIITA expression on (a) the activity 
of an MHC class II promoter in transient transfection ex- 
periments, and (b) the activity of the endogenous MHC class 
II genes in stably transfected  cells. Transient  cotransfection 
experiments using the CIITA cDNA and DRA promoter- 
CAT constructs demonstrate that an inactive MHC class II 
promoter can be reactivated in plasmocytes by expression of 
CIITA (Fig. 5 A). The level attained by this trans-activation 
is comparable to that observed in the class II-negative B cell 
regulatory mutant line RJ2.2.5  (data  not shown). 
SKO cells were transfected with the CIITA expression vector 
and stably transfected  cells were isolated.  In these transfec- 
tants, expression of all three HLA class II isotypes, HLA- 
DR,  -DQ,  and -DP,  is reactivated  (Fig.  5 B, pands 5-7). 
The level of class II expression in these CIITA-transfected 
plasmocytes is comparable to that observed in the B lympho- 
cyte line RAJI. Stable transfectants  obtained after transfec- 
tion with the expression vector alone (EBO-76PL)  do not 
show any effect on the phenotype of SKO ceils (Fig. 5, B, 
panels 1-3) demonstrating that the effect of the CIITA (EBO- 
Sfi/CIITA) is indeed specific. This effect of CIITA is not 
limited to human plasmocytes, since transfection of the class 
II-negative mouse plasmocytoma  line P3U1 (kindly provided 
by R. Accolla, Institute of Immunology, Verona,  Italy) by 
human CIITA eDNA leads to expression of both IA and IE 
molecules (data  not shown). 
Figure 4.  CIITA gene is silent in plasmocytoma cells. Total RNA was 
hybridized to a CIITA riboprobe complementary to nucleotides 1824-2049. 
After hybridization,  RNAs were digested with RNase A and T1. Pro- 
tected fragments  of 225 nt were purified and resolved on a denaturing 
6% polyacrylamide-8 M Urea gel. Lane I : RAJI; lane 2; SKO; and lane 
3: undigested probe. The quantity and quality of the KNA were con- 
trolled by hybridization  to a TBP specific probe (data not shown). 
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sion in phsmocytoma  cells. (.4) 20 #g of the pDRACAT plasmid was 
cotran&s:ted  with increasing  amounts  of  the CIITA  e~pression  vector  EBO- 
Sfi/CIITA  (column  I: none;  cohmn 2:5/*g; column  3:10 #g, and coluran 
4:20 #g). CAT activity  was determined  48 h after  transfection.  (B) MHC 
class II gene ~pression was analyzed  by flow cytoflnorometry  in stable 
tnmf~tants obtained  by ~on  of  SKO with EBO-76PL  (pands 1-4) 
and EBO-Sfi/CIITA  (panels  5-8). mAbs  used  in these  ezperiments  were: 
2.06 (HLA-DK,  pands 1 and 5), Tfi22 (HLA-DQ,  panels  2 and 6), B7/21 
(HLA-DP, panels 3 and 7), W6.32 (MHC class I, panels 4 and 8). 
We conclude that in plasmocytes MHC dass II genes are 
silent, because the CIITA gene is not expressed. Experimen- 
tally induced reexpression of CIITA in these cells is suflficient 
to restore normal levels of MHC class II gene expression. 
Discussion 
Extinction of MHC class II gene expression represents an 
interesting model for the study of the developmental control 
of gene regulation. The ontogeny of B ceils is characterized 
by profound phenotypic changes, associated with extensive 
modifications of B lymphocyte function. MHC dass II ex- 
pression is modulated during this process.  Class II molecules 
are primarily responsible for restricted B-T cell interactions, 
required to trigger an immune response directed against a 
foreign antigen (1, 2). During B cell maturation, MHC dass 
II-restricted interaction with T  lymphocytes also allows T 
calls and their cytokines to play an important role in this de- 
velopmental process (41). 
During the last step of B cell ontogeny, mature B lym- 
phocytes disengage from T cells, acquire a highly developed 
secretory machinery, and differentiate into phsma cells, whose 
major function is to secrete Ig molecules. This change in func- 
tion is also characterized by a loss in the expression of  numerous 
genes, including MHC class II genes (12, 22, 23). It has been 
suggested from the results of cell fusion experiments, that 
extinction of dass II genes in plasma cells results from a dom- 
inant mechanism. In hybridomas obtained by fusion between 
a MHC dass II-positive human B cell line and a mouse plas- 
mocytoma cell line, expression of the MHC class II genes 
is turned off, suggesting the existence of a repressor activity 
in the plasmocytoma ceils  (22,  23). 
To darify the molecular mechanism responsible for the ex- 
tinction of MHC dass II genes during the terminal differen- 
tiation of B cells into plasmocytes, we have extended the anal- 
ysis of class II promoters and, more importantly, have explored 
the possible role of the newly discovered MHC class II trans- 
activator CIITA. We first confirmed that the defect in MHC 
dass II genes is transcriptional and identified the minimal 
sequence requirements, within MHC class II promoters, that 
confer the MHC class II-negative phenotype to plasmocytes. 
The first 150 bp of the DRA promoter, active in RAJI ceUs, 
are silent in SKO cells (Fig.  1). This region of the promoter 
includes all the conserved class II consensus boxes previously 
described by sequence comparisons and functional assays (3-5, 
20). These sequences are unoccupied in dass II-negative plas- 
mocytes, although all factors known to bind to these class 
II promoter motifs in B cells are present normally in nuclear 
extracts from plasmocytes and are capable of  binding in vitro 
to their target sites in the promoter. We conclude that these 
DNA binding factors are not missing but that they cannot 
form a stable transcriptional complex in intact cells. 
It was then possible to ask whether the observed develop- 
mental extinction of MHC class II genes results from a di- 
rect effect on the class II gene promoter or whether it is con- 
trolled at the level of a positive trans-acting  factor required 
for MHC class II gene expression. The lack of expression 
of CIITA in plasmocytes suggested a role for CIITA in MHC 
class  II  gene extinction.  This was confirmed by showing 
directly that experimentally induced expression of CIITA in 
plasmocytes restores full expression of MHC class II genes. 
In these cells, expression of CIITA also leads to reoccupation 
of the class II promoter elements (data not shown). The level 
1333  Silacci  et al. MATURE  B  CELL 
~ 
EPRE~ 
PLASMA  CELL 
Figure 6.  A model for the ex- 
tinction of the MHC class II gene 
expression during the differentiation 
of  mature  B  lymphocytes  into 
plasma cells. In mature B lympho- 
cytes all the regulatory  f~ors neces- 
sary for MHC class II gene expres- 
sion, including CIITA, are normally 
expressed. During the differentia- 
tion of phsma cells  a novel  repressor 
function is activated. The target of 
this repressor  function is the CIITA 
gene, which is therefore silenced in 
plasma cells. As a consequence of 
the extinction of the CIITA gene 
expression, MHC class II genes can 
no longer be transcribed. 
of HLA-DR, -DO, and -DP molecules expressed at the sur- 
face of these transfected plasmocytes is comparable to that 
of B cell lines.  Expression of IA and IE is also restored by 
CIITA in the mouse plasmocytoma cell line P3U1, demon- 
strating  that  the results obtained here are not restricted to 
the SKO cell line. 
Based on these results, we propose a model for MHC dass 
II gene extinction in plasma cell that is based on the activa- 
tion of a repressor function during the differentiation of B 
cells to plasma cells. This repression is acting on the expres- 
sion of the CIITA gene, a transcription  factor whose pres- 
ence is essential for MHC class II transcription,  rather than 
directly on the MHC class II promoter itself (Fig.  6). The 
model presented is also consistent with recent observations 
(42) which showed in transient  heterokaryons obtained by 
cell fusion experiments between a mouse plasmocytoma cell 
line (P3U1) and human B cell line (RAJI), a reactivation of 
the murine MHC class II gene expression 48-72 h after fu- 
sion. We propose that in these heterokaryons, transcription 
of the murine MHC class II genes is due to the presence and 
the effect of CIITA provided from the RAJI cells.  The ap- 
parent discordance between these observations and earlier cell 
fusion experiments, involving stable hybridomas (22, 23), can 
thus be explained by the half-life  of the CIITA regulatory 
protein. 
These findings open the way for future studies on the mode 
of extinction of the CIITA gene itself in differentiated plas- 
mocytes. Factors responsible for CIITA extinction could even 
be cloned by direct expression of plasmocyte eDNA libraries 
in a normal  B cell line and by selection for loss of MHC 
class II expression. The mechanism of action of CIITA on 
MHC class II transcription is still unclear. The CIITA pro- 
tein itself does not bind to MHC class II promoters and it 
has been suggested that it functions by interacting with other 
proteins bound to the promoter (21). In transfected plasmo- 
cytes, CIITA is capable of inducing occupancy of MHC class 
II promoters by the various transcription  factors that bind 
to the class II consensus boxes. CIITA might well favor and 
reenforce the cooperative binding described recently between 
RF-X, X2BP, and NF-Y (40, 40a) above a certain function- 
ally relevant threshold and thus allow promoter occupancy 
and transcription  to take place. 
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